Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor

All categories

DBCAT003351Therapeutic category

A DrugBank category of 8 drugs. 6 of them are approved.

Drugs: Adefovir
Adefovir dipivoxil
Entecavir
Lamivudine
Telbivudine
Tenofovir
Tenofovir alafenamide
Tenofovir disoproxil

What you can answer from here — as of October 25, 2017

8DrugsEach linked to its full drug card

Listed above

8Drug targetsEvery drug–target pair in the class, with bond type

1,970Marketed productsAcross the regions we cover, with dosage forms and routes

3Routes of administrationHow the drugs in this class are given

Which targets do Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account